Literature DB >> 27559087

Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes.

Won-Suk Chung1, Philip B Verghese2, Chandrani Chakraborty3, Julia Joung3, Bradley T Hyman4, Jason D Ulrich2, David M Holtzman2, Ben A Barres5.   

Abstract

The strongest genetic risk factor influencing susceptibility to late-onset Alzheimer's disease (AD) is apolipoprotein E (APOE) genotype. APOE has three common isoforms in humans, E2, E3, and E4. The presence of two copies of the E4 allele increases risk by ∼12-fold whereas E2 allele is associated with an ∼twofold decreased risk for AD. These data put APOE central to AD pathophysiology, but it is not yet clear how APOE alleles modify AD risk. Recently we found that astrocytes, a major central nervous system cell type that produces APOE, are highly phagocytic and participate in normal synapse pruning and turnover. Here, we report a novel role for APOE in controlling the phagocytic capacity of astrocytes that is highly dependent on APOE isoform. APOE2 enhances the rate of phagocytosis of synapses by astrocytes, whereas APO4 decreases it. We also found that the amount of C1q protein accumulation in hippocampus, which may represent the accumulation of senescent synapses with enhanced vulnerability to complement-mediated degeneration, is highly dependent on APOE alleles: C1q accumulation was significantly reduced in APOE2 knock-in (KI) animals and was significantly increased in APOE4 KI animals compared with APOE3 KI animals. These studies reveal a novel allele-dependent role for APOE in regulating the rate of synapse pruning by astrocytes. They also suggest the hypothesis that AD susceptibility of APOE4 may originate in part from defective phagocytic capacity of astrocytes which accelerates the rate of accumulation of C1q-coated senescent synapses, enhancing synaptic vulnerability to classical-complement-cascade mediated neurodegeneration.

Entities:  

Keywords:  APOE allele; C1q; astrocytes; phagocytosis; synapse elimination

Mesh:

Substances:

Year:  2016        PMID: 27559087      PMCID: PMC5018780          DOI: 10.1073/pnas.1609896113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein.

Authors:  Masaaki Narita; David M Holtzman; Anne M Fagan; Mary Jo LaDu; Li Yu; Xianlin Han; Richard W Gross; Guojun Bu; Alan L Schwartz
Journal:  J Biochem       Date:  2002-11       Impact factor: 3.387

Review 2.  The double-edged flower: roles of complement protein C1q in neurodegenerative diseases.

Authors:  Andrea J Tenner; Maria I Fonseca
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.

Authors:  R E Hartman; D F Wozniak; A Nardi; J W Olney; L Sartorius; D M Holtzman
Journal:  Exp Neurol       Date:  2001-08       Impact factor: 5.330

4.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

5.  Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury.

Authors:  A M Fagan; B A Murphy; S N Patel; J F Kilbridge; W C Mobley; G Bu; D M Holtzman
Journal:  Exp Neurol       Date:  1998-06       Impact factor: 5.330

6.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

7.  Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.

Authors:  M J LaDu; T M Pederson; D E Frail; C A Reardon; G S Getz; M T Falduto
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

8.  Complement and microglia mediate early synapse loss in Alzheimer mouse models.

Authors:  Victoria F Beja-Glasser; Bianca M Nfonoyim; Soyon Hong; Arnaud Frouin; Shaomin Li; Saranya Ramakrishnan; Katherine M Merry; Qiaoqiao Shi; Arnon Rosenthal; Ben A Barres; Cynthia A Lemere; Dennis J Selkoe; Beth Stevens
Journal:  Science       Date:  2016-03-31       Impact factor: 47.728

9.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.

Authors:  C E Matz; A Jonas
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

10.  TAM receptors regulate multiple features of microglial physiology.

Authors:  Lawrence Fourgeaud; Paqui G Través; Yusuf Tufail; Humberto Leal-Bailey; Erin D Lew; Patrick G Burrola; Perri Callaway; Anna Zagórska; Carla V Rothlin; Axel Nimmerjahn; Greg Lemke
Journal:  Nature       Date:  2016-04-06       Impact factor: 49.962

View more
  89 in total

1.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

Review 2.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

3.  Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.

Authors:  Hari Prasad; Rajini Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-26       Impact factor: 11.205

4.  Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.

Authors:  Chia-Chen Liu; Jin Hu; Na Zhao; Jian Wang; Na Wang; John R Cirrito; Takahisa Kanekiyo; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

Review 5.  Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders.

Authors:  Urte Neniskyte; Cornelius T Gross
Journal:  Nat Rev Neurosci       Date:  2017-09-21       Impact factor: 34.870

6.  Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer's Disease-like Pathology.

Authors:  Jeffrey N Savas; Yi-Zhi Wang; Laura A DeNardo; Salvador Martinez-Bartolome; Daniel B McClatchy; Timothy J Hark; Natalie F Shanks; Kira A Cozzolino; Mathieu Lavallée-Adam; Samuel N Smukowski; Sung Kyu Park; Jeffery W Kelly; Edward H Koo; Terunaga Nakagawa; Eliezer Masliah; Anirvan Ghosh; John R Yates
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.423

Review 7.  Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.

Authors:  Sreedevi Raman; Nicholas Brookhouser; David A Brafman
Journal:  Neurobiol Dis       Date:  2020-02-05       Impact factor: 5.996

8.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

Review 9.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

10.  CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness.

Authors:  Natalia Lago; Fernanda N Kaufmann; María Luciana Negro-Demontel; Daniela Alí-Ruiz; Gabriele Ghisleni; Natalia Rego; Andrea Arcas-García; Nathalia Vitureira; Karen Jansen; Luciano M Souza; Ricardo A Silva; Diogo R Lara; Bruno Pannunzio; Juan Andrés Abin-Carriquiry; Jesús Amo-Aparicio; Celia Martin-Otal; Hugo Naya; Dorian B McGavern; Joan Sayós; Rubèn López-Vales; Manuella P Kaster; Hugo Peluffo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.